trial,pubID,pseudogroup,weeks,group,IgD-/IgM-/IgA-/IgG+/KO-/Antigen++ B cells
G002,G002-852,3.0,16,1,948.0
G002,G002-988,3.0,16,3,2235.0
G002,G002-577,4.0,16,2,1485.0
G002,G002-616,3.0,16,1,718.0
G002,G002-931,3.0,16,3,819.0
G002,G002-230,4.0,16,2,2239.0
G002,G002-630,4.0,16,2,1036.0
G002,G002-943,4.0,16,2,1161.0
G002,G002-678,3.0,16,1,686.0
G002,G002-884,3.0,16,3,608.0
G002,G002-796,3.0,16,3,874.0
G002,G002-145,4.0,16,2,2357.0
G002,G002-997,3.0,16,3,692.0
G002,G002-341,4.0,16,2,885.0
G002,G002-119,4.0,16,2,628.0
G002,G002-619,3.0,16,1,362.0
G002,G002-304,3.0,16,3,136.0
G002,G002-632,3.0,16,3,416.0
G002,G002-855,4.0,16,2,314.0
G002,G002-820,4.0,16,2,1390.0
G002,G002-427,3.0,16,3,317.0
G002,G002-947,4.0,16,2,230.0
G002,G002-758,3.0,16,1,299.0
G002,G002-477,3.0,16,3,369.0
G002,G002-866,3.0,16,3,239.0
G002,G002-969,3.0,16,1,150.0
G002,G002-302,3.0,16,1,285.0
G002,G002-293,4.0,16,2,1513.0
G002,G002-546,3.0,16,1,156.0
G002,G002-278,3.0,16,3,144.0
G002,G002-620,4.0,16,2,151.0
G002,G002-136,4.0,16,2,299.0
G002,G002-595,3.0,16,3,166.0
G002,G002-813,3.0,16,1,175.0
G002,G002-957,4.0,16,2,349.0
G002,G002-462,3.0,16,3,239.0
G002,G002-810,3.0,16,3,256.0
G002,G002-516,3.0,16,1,54.0
G002,G002-480,4.0,16,2,83.0
G002,G002-493,4.0,16,2,240.0
G002,G002-371,3.0,16,3,21.0
G002,G002-905,3.0,16,1,91.0
G002,G002-834,3.0,16,1,69.0
G002,G002-825,3.0,16,3,86.0
